Oncolytics Biotech - ADR Financials

$0.84

$-0.01 (-1.55%)

As on 04-Sep-2026 16:06EDT

Market cap

$108 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1055

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-20.11	-19.88	-21.44	-17.21	-22.43
Cash Flow from Investing Activities	--	-0.01	-0.17	15.24	-15.03	-0.29
Cash from Financing Activities	--	14.12	5.03	24.12	8.99	33.02
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.35	-0.27	-0.28	-0.28	-0.31	-0.48
Cash EPS ($)	-0.34	-0.27	-0.28	-0.28	-0.30	-0.47
Adjusted Book Value ($)	-0.05	--	0.07	0.37	0.45	0.66
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.19	-0.25	-0.29	-0.29	-0.41
Free Cash Flow per Share ($)	--	-0.19	-0.25	-0.29	-0.29	-0.41

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-2,206.47	-130.13	-76.26	-57.52	-84.98
ROE (%)	--	-7,467.16	-135.90	-77.39	-58.46	-86.45
ROA (%)	-193.82	-188.03	-77.26	-54.94	-43.98	-65.58
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-31.94	-12.46	-0.28	-28.40	24.38	-3.05
Net Profit Growth (%)	-63.87	-26.17	-8.96	-14.32	30.43	-16.88
EPS Growth (%)	-21.75	0.07	0.00	0.08	0.36	0.11
Book Value Growth (%)	-176.97	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-3.28	-3.21	-4.76	-5.30	-2.90
Price / Book Value	1,055.04	-18.11	12.22	3.61	3.66	2.12
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.79	-3.07	-2.29	-2.45	-3.34	-1.34
Close Price ($)	0.95	0.87	0.91	1.35	1.63	1.39
High Price ($)	1.51	1.51	1.53	3.39	2.28	4.83
Low Price ($)	0.71	0.33	0.71	1.09	0.80	1.37
Market Cap ($ Cr)	107.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.15	0.18	0.02	0.01	0.02
Short term debt to equity ratio	-0.02	-0.05	0.05	0.00	0.01	0.01
Current Ratio	1.35	1.12	2.82	9.01	9.05	16.69
Quick Ratio	1.35	--	--	--	--	--
Interest Coverage	--	--	--	--	-37.57	-189.52

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	15,379.49	4,553.03	2,039.18	1,726.12	1,215.06
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.